Skip to main navigation Skip to search Skip to main content

Treatment of Arsenic-Induced Bowen’s Disease With Topical 5-Fluorouracil

  • Brendon Verhave
  • , Matthew Goldberg
  • , Peter Hashim
  • , Jacob Levitt

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Here, we present a case of arsenic-induced Bowen’s disease treated with a regimen consisting of topical 5-fluouracil and oral nicotinamide. The use of this therapy modality resulted in near complete resolution of all of the patient’s lesions except for those on her palms, soles, and scalp. Excellent wound care and treatment adherence were major factors contributing to the success of this treatment option. Our results ultimately provide an alternative approach to treating multiple arsenical keratoses in patients who are limited to a drug plan involving 5-FU and oral nicotinamide and who are able to be rigorously compliant with application of medication and wound care.

Original languageEnglish
Pages (from-to)477-479
Number of pages3
JournalJournal of Drugs in Dermatology
Volume18
Issue number5
StatePublished - May 2019
Externally publishedYes

Fingerprint

Dive into the research topics of 'Treatment of Arsenic-Induced Bowen’s Disease With Topical 5-Fluorouracil'. Together they form a unique fingerprint.

Cite this